Rectal Cancer: Neoadjuvant Therapy
Rectal Cancer: Neoadjuvant Therapy is a topic covered in the ASCRS Textbook of Colon and Rectal Surgery.
To view the entire topic, please log in or purchase a subscription.
ASCRS U Education Portal is the one-stop place for all things related to colorectal surgery. Provided by the American Society of Colon & Rectal Surgeons. Powered by Unbound Medicine. Explore these free sample topics:
-- The first section of this topic is shown below --
Key Concepts
- Standardized surgery using the total mesorectal excision concept remains paramount for achieving local control for rectal cancer.
- Addition of neoadjuvant therapy (short-course radiation, long-course chemoradiation) along with standardized surgery improves local control.
- Neoadjuvant short-course radiation therapy and long-course chemoradiation therapy have not improved DFS or OS for patients with LARC.
- Increased time interval between the completion of radiation therapy and surgery directly impacts the pathologic response of the primary tumor.
- The administration of systemic multidrug chemotherapy in the neoadjuvant setting as either induction or consolidation relative to radiation therapy has led to improved primary tumor response, improved tolerance, and improved delivery.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
Key Concepts
- Standardized surgery using the total mesorectal excision concept remains paramount for achieving local control for rectal cancer.
- Addition of neoadjuvant therapy (short-course radiation, long-course chemoradiation) along with standardized surgery improves local control.
- Neoadjuvant short-course radiation therapy and long-course chemoradiation therapy have not improved DFS or OS for patients with LARC.
- Increased time interval between the completion of radiation therapy and surgery directly impacts the pathologic response of the primary tumor.
- The administration of systemic multidrug chemotherapy in the neoadjuvant setting as either induction or consolidation relative to radiation therapy has led to improved primary tumor response, improved tolerance, and improved delivery.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: January 26, 2022
Citation
Hunt, Steven R, and Matthew G Mutch. "Rectal Cancer: Neoadjuvant Therapy." ASCRS Textbook of Colon and Rectal Surgery, 2022. ASCRS, www.ascrsu.com/ascrs/view/ASCRS-Textbook-of-Colon-and-Rectal-Surgery/2285019/all/Rectal_Cancer:_Neoadjuvant_Therapy.
Hunt SR, Mutch MG. Rectal Cancer: Neoadjuvant Therapy. ASCRS Textbook of Colon and Rectal Surgery. 2022. https://www.ascrsu.com/ascrs/view/ASCRS-Textbook-of-Colon-and-Rectal-Surgery/2285019/all/Rectal_Cancer:_Neoadjuvant_Therapy. Accessed January 31, 2023.
Hunt, S. R., & Mutch, M. G. (2022). Rectal Cancer: Neoadjuvant Therapy. In ASCRS Textbook of Colon and Rectal Surgery https://www.ascrsu.com/ascrs/view/ASCRS-Textbook-of-Colon-and-Rectal-Surgery/2285019/all/Rectal_Cancer:_Neoadjuvant_Therapy
Hunt SR, Mutch MG. Rectal Cancer: Neoadjuvant Therapy [Internet]. In: ASCRS Textbook of Colon and Rectal Surgery. ; 2022. [cited 2023 January 31]. Available from: https://www.ascrsu.com/ascrs/view/ASCRS-Textbook-of-Colon-and-Rectal-Surgery/2285019/all/Rectal_Cancer:_Neoadjuvant_Therapy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rectal Cancer: Neoadjuvant Therapy
ID - 2285019
A1 - Hunt,Steven,
AU - Mutch,Matthew,
Y1 - 2022/01/26/
BT - ASCRS Textbook of Colon and Rectal Surgery
UR - https://www.ascrsu.com/ascrs/view/ASCRS-Textbook-of-Colon-and-Rectal-Surgery/2285019/all/Rectal_Cancer:_Neoadjuvant_Therapy
DB - ASCRS
DP - Unbound Medicine
ER -